Metraipolis › archive › dc_f8bf3ee6b8bb

Regulatory Approval Is Not Enough: Gaps in Trustworthy AI Reporting in FDA-Cleared Medical Devices — arXiv:2608.12360

Source
arXiv (en)
Original
https://arxiv.org/abs/2608.12360
License (as archived)
CC0-1.0
Archived
2026-10-19T04:24:59.862Z
SHA-256 of the archived text
e48abaa901361d124f3c70da191de90ae7686ef2770ee7e48ddf13dbf6f85afa
Stable URL of this page
https://metraipolis.com/documento/dc_f8bf3ee6b8bb

How to cite

Regulatory Approval Is Not Enough: Gaps in Trustworthy AI Reporting in FDA-Cleared Medical Devices — arXiv:2608.12360 — arXiv (en), https://arxiv.org/abs/2608.12360 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f8bf3ee6b8bb (Metraipolis archive dc_f8bf3ee6b8bb, sha256 e48abaa901361d124f3c70da191de90ae7686ef2770ee7e48ddf13dbf6f85afa)
BibTeX
@misc{dcf8bf3ee6b8bb,
  title = {Regulatory Approval Is Not Enough: Gaps in Trustworthy AI Reporting in FDA-Cleared Medical Devices — arXiv:2608.12360},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2608.12360},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f8bf3ee6b8bb; sha256 e48abaa901361d124f3c70da191de90ae7686ef2770ee7e48ddf13dbf6f85afa},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.12360. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: AI/ML-enabled medical devices are increasingly deployed in healthcare under evolving regulatory frameworks. As these systems become more integrated into clinical decision-making, there is growing expectation that they demonstrate key dimensions of trustworthy AI to support clinician, patient, and public trust. Whether publicly available regulatory documentation provides sufficient evidence to independently assess the trustworthiness of cleared AI systems remains unclear. Methods: We analysed FDA AI/ML-enabled medical device summary reports published between 2021 and 2025. Reports underwent automated keyword screening followed by multi-stage manual consensus review to identify documented evidence for the six FUTURE-AI principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability. Descriptive, temporal, and clinical-domain analyses were performed. Multivariable logistic regression assessed whether year of clearance or clinical domain predicted higher reporting transparency, defined as evidence reported for three or more principles. Results: Of 1,105 FDA summary reports screened, 519 were included. Trustworthy AI reporting was limited and uneven. Nearly one quarter (24.7%) provided no evidence for any principle, and none documented evidence across all six. Robustness was most frequently reported (57.6%), while Traceability (8.3%) and Explainability (3.5%) were the most pronounced gaps. Neither year of clearance (OR 1.02, 95% CI 0.88-1.19) nor clinical domain (OR 0.73, 95% CI 0.46-1.15) predicted higher reporting transparency. Interpretation: Substantial, persistent trustworthy AI reporting gaps exist in FDA documentation. Regulatory approval alone should not be considered a proxy for trustworthiness. Standardised, audit-ready reporting across the AI lifecycle is needed to support independent assessment and responsible adoption of healthcare AI.

Tema degli esploratori: governance digitale e beni comuni (retro-catalogo arXiv: annunci del 2026-08-14 in cs.CY).
Categorie arXiv: Computers and Society (cs.CY) ; Machine Learning (cs.LG).
Pagina del lavoro: https://arxiv.org/abs/2608.12360 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-19T04:18:45.152Z dalla pagina https://arxiv.org/catchup/cs.CY/2026-08-14?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).